Anti-Hypertensive Drugs Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: October 28, 2020 |

The global anti-hypertensive drugs market size was accounted for around USD 23 billion in 2019 and anticipated to grow at a significant CAGR of 2.17% during the forecast period 2020-2027. Hypertension is among the most commonly witnessed chronic conditions, where elevation in systolic and diastolic blood pressure is observed. Hypertension is touted to be a precursor to other severe conditions such as renal and cardiovascular disorders. Sedentary lifestyle, obesity, and aging are the key risk factors for hypertension. Anti-hypertensive drugs are administered to reduce blood pressure, where different drug classes with varied mechanisms of action are currently commercially available. As the target patient pool is perpetually rising, this market will witness gradual growth with further anticipation of the introduction of novel drugs in this space.

Market Insights:

Hypertension is among the most commonly witnessed and prevalent chronic conditions and is characterized by heightened systolic and diastolic pressure. Antihypertensive drugs such as ACE inhibitors, ARBs, calcium channel blockers, beta-adrenergic blockers, alpha-adrenergic blockers, central sympatholytic, renin inhibitors, and vasodilators are used for the treatment and management of hypertension. The prevalence of hypertension is observed to be perpetually growing, particularly in regions characterized by a large pool of high-risk senescent population, high obesity prevalence, and subject to lifestyle factors. The market size for anti-hypertensive drugs is observed to be large in developed parts of the world such as North America and Western Europe. However, regions such as Asia Pacific, and Middle East and Africa are witnessing significant growth in the light of huge general population and growing disease prevalence.

Market Segment Insights:

Based on drug types, the global anti-hypertensive drugs market is categorized into diuretics, ACE inhibitors, ARBs, calcium channel blockers, beta-adrenergic blockers, alpha-adrenergic blockers, central sympatholytic, renin inhibitors, and vasodilators. Among these, ACE inhibitors are the most widely used drug type as it controls blood pressure by relaxing blood vessels and decreasing blood volume. These drugs inhibit the angiotensin-converting enzyme, a critical component of the renin-angiotensin system. Some of the most frequently prescribed ACE inhibitors are benazepril, zofenopril, ramipril, perindopril, enalapril, trandolapril, captopril, and lisinopril. Diuretics are the next most commonly prescribed form of anti-hypertensive drugs and are widely available in the market. These drugs reduce blood pressure by reducing sodium and water from the body. As new and more effective drugs are being introduced in the market, the preference for using diuretics as first-line treatment is observed to be lowered.

Global Anti-hypertensive Drugs Market Segmentation:

By Drug Type, 2018–2027 ($ Millon)

  • Diuretics
  • ACE Inhibitors
  • ARBs
  • Calcium Channel Blockers
  • Beta-Adrenergic Blocker
  • Alpha – Adrenergic Blocker
  • Central Sympatholyics
  • Renin-inhibitors
  • Vasodilators

By Geography, 2018-2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Regional Insights:

For the purpose of this study, the global antioxidants market is regionally categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa markets. These regional markets are further sub-segmented into top country-level markets that majorly determine the regional industry trends. Among the considered regional markets, North America currently dominates the global antioxidants market and is anticipated to retain its dominance through the forecast period. The high prevalence of hypertension in the region, a large pool of senescent population, anticipated early commercialization of novel drugs in the U.S. market significantly contribute to the dominance of North America on the global front. On the other hand, with perpetual rise in CVD patients, Asia Pacific is observed to be the fastest progressing market for anti-hypertensive drugs. Asia Pacific houses approximately half of CVD patients, out of which over 60% suffer from hypertension.

Market Competition Assessment:

Astra Zeneca, Daiichyi Sankyo Co. Ltd., Takeda Pharmaceutical, Sanofi, Merck & Co., Boehinger Ingelheim, Pfizer, Bayer AG, Lupin Limited, Johnson & Johnson, Actelion Ltd., Ranbaxy Laboratories Limited and others are some of the major players operating in the global anti-hypertensive drugs market.

List of Key Players:

  • Actelion Ltd
  • Astra Zeneca
  • Bayer AG
  • Boehinger Ingelheim
  • Daiichyi Sankyo Co. Ltd.
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co.
  • Novartis AG
  • Pfizer
  • Ranbaxy Laboratories Limited
  • Sanofi

For more information, request a report sample @ https://www.researchcorridor.com/request-sample/?id=9423

Key Questions Answered by Anti-Hypertensive Drugs Market Report

  • Global anti-hypertensive drugs market forecasts from 2020-2027
  • Regional anti-hypertensive drugs market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
  • Anti-Hypertensive Drugs submarket forecasts from 2020-2027 covering the market by drug type, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to anti-hypertensive drugs market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country level anti-hypertensive drugs markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the anti-hypertensive drugs market

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying

Table of Content:


Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Market Portraiture
2.2 Global Anti-Hypertensive Drugs Market Share, by Drug Type, 2019 ($ Million)
2.3 Global Anti-Hypertensive Drugs Market, by Geography, 2019 (Value %)
Chapter 3 Global Anti-Hypertensive Drugs Market Analysis
3.1 Hypertension
3.1.1 Epidemiology
3.1.2 Treatment
3.2 Prescription Analysis
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Prevalence of chronic diseases
3.3.1.2 Rise in R&D and new drug approval
3.3.2 Challenges
3.3.2.1 Adverse effects of anti-hypertensive
3.3.3 Opportunities
3.3.3.1 Use of combination therapy and to address the unmet needs
3.4 Attractive Investment Proposition
3.5 Pipeline Analysis
3.6 Market Positioning of Key Players in Anti-Hypertensive Drugs
Chapter 4 Global Anti-Hypertensive Drugs Market Analysis, by Drug Type, 2018-2027 (US$ Mn)
4.1 Introduction
4.2 Diuretics
4.3 ACE inhibitors
4.4 ARBs
4.5 Calcium Channel Blockers
4.6 Beta - Adrenergic blocker
4.7 Alpha - Adrenergic blocker
4.8 Central Sympatholyics
4.9 Renin inhibitors
4.10 Vasodilators
Chapter 5 Global Anti-Hypertensive Drugs Market, by Geography, 2018-2027 ($ Million)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
Chapter 6 Company Profiles
6.1 Novartis AG
6.2 Astra zeneca
6.3 Daiichyi Sankyo Co. Ltd
6.4 Takeda Pharmaceutical
6.5 Sanofi
6.6 Merck & Co
6.7 Boehinger Ingelheim
6.8 Pfizer
6.9 Bayer AG
6.10 Lupin Limited
6.11 Johnson & Johnson
6.12 Actelion Ltd
6.13 Ranbaxy Laboratories Limited
6.14 Other Notable Players
Fill the given form to inquiry before buying for Anti-Hypertensive Drugs Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com